Adalimumab and infliximab survival in patients with hidradenitis suppurativa: a daily practice cohort study. Prens LM, Bouwman K, Aarts P, Arends S, et al. Br J Dermatol 2021;185:177-184.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Prens LM, Bouwman K, Aarts P, Arends S, et al. Adalimumab and infliximab survival in patients with hidradenitis suppurativa: a daily practice cohort study. Br J Dermatol 2021;185:177-184.
PMID: 33544917